REQUEST A DEMO
Total
USD $0.00
Search more companies

K.N.A. Inter Pharma Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: K.N.A. Inter Pharma Company Limited Profile Updated: August 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

K.N.A. Inter Pharma Company Limited is an enterprise located in Thailand, with the main office in Nakhon Sawan. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on August 22, 2026. There are currently 12 (estimated) people employed by K.N.A. Inter Pharma Company Limited. In its most recent financial highlights, the company reported a net sales revenue increase of 0.78% in 2025. Its’ total assets recorded a growth of 182.28%. K.N.A. Inter Pharma Company Limited’s net profit margin increased by 5.39% in 2025.

Headquarters
175-175/1 Sawan Withee Road
Nakhon Sawan; Central Thailand; Postal Code: 60000

Contact Details: Purchase the K.N.A. Inter Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the K.N.A. Inter Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the K.N.A. Inter Pharma Company Limited report to view the information.
Incorporation Date:
August 22, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after K.N.A. Inter Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
0.78%
Total Operating Revenue
0.78%
Operating Profit
277.12%
Net Profit/Loss for the Period
276.88%
Total Assets
182.28%
Total Equity
128.39%
Operating Profit Margin
6.74%
Net Profit Margin
5.39%
Return on Equity (ROE)
22.14%
Quick Ratio
0.45%
Cash Ratio
-0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?